On Friday night during Jim Cramer's Mad Money program, he identified another high flier this year, InMode (INMD) , which has soared about 213% this year. Cramer said he still loves this company's medical aesthetics technology that doesn't require invasive surgery. He loves that the company is profitable with accelerating revenue growth. But you can't be greedy, and should lock in some of your gains before the end of the year.
More from Investing
Here are the areas I'm buying, and here and the areas of which I'm turning away in disgust.
I see three key takeaways from Wednesday's FOMC release.
Shares of PSX have made an upside breakout, so investors can step on the gas.